NO20071795L - Octenidin-inneholdende tabletter anvendt mot betennelsessykdommer i munn og svelg - Google Patents

Octenidin-inneholdende tabletter anvendt mot betennelsessykdommer i munn og svelg

Info

Publication number
NO20071795L
NO20071795L NO20071795A NO20071795A NO20071795L NO 20071795 L NO20071795 L NO 20071795L NO 20071795 A NO20071795 A NO 20071795A NO 20071795 A NO20071795 A NO 20071795A NO 20071795 L NO20071795 L NO 20071795L
Authority
NO
Norway
Prior art keywords
octenidine
throat
mouth
inflammatory diseases
lozenge
Prior art date
Application number
NO20071795A
Other languages
English (en)
Inventor
Holger Miething
Original Assignee
Divapharma Knufinke Arzneimitt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Divapharma Knufinke Arzneimitt filed Critical Divapharma Knufinke Arzneimitt
Publication of NO20071795L publication Critical patent/NO20071795L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives en sugetablett, særlig på hårdkaramell-basis, egnet til topisk behandling av betennelsessykdommer i munn og svelg, hvor sugetabletten som virkestoff inneholder octenidin, fortrinnsvis i form av octenidin-dihydrokloridet, slik at en terapeutisk virksom mengde octenidin, fortrinnsvis octenidin-dihydroklorid, frigjøres ved suging når sugetabletten administreres til pasientens munn og svelg og suges.
NO20071795A 2004-10-12 2007-04-03 Octenidin-inneholdende tabletter anvendt mot betennelsessykdommer i munn og svelg NO20071795L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004049798 2004-10-12
DE102004052308A DE102004052308B4 (de) 2004-10-12 2004-10-28 Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums
PCT/EP2005/008973 WO2006039961A1 (de) 2004-10-12 2005-08-19 Octenidinhaltige lutschtabletten gegen entzündliche erkrankungen des mund- und rachenraums

Publications (1)

Publication Number Publication Date
NO20071795L true NO20071795L (no) 2007-07-06

Family

ID=35149087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071795A NO20071795L (no) 2004-10-12 2007-04-03 Octenidin-inneholdende tabletter anvendt mot betennelsessykdommer i munn og svelg

Country Status (14)

Country Link
EP (1) EP1799186B1 (no)
CN (1) CN101052373B (no)
AT (1) ATE398441T1 (no)
DE (2) DE102004052308B4 (no)
EA (1) EA011991B1 (no)
ES (1) ES2309790T3 (no)
GE (1) GEP20094809B (no)
HR (1) HRP20080438T3 (no)
NO (1) NO20071795L (no)
PL (1) PL1799186T3 (no)
RS (1) RS50593B (no)
SI (1) SI1799186T1 (no)
UA (1) UA83320C2 (no)
WO (1) WO2006039961A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101560176B1 (ko) 2007-10-31 2015-10-14 맥네일-피피씨, 인코포레이티드 구강내 붕해성 투여 형태
RU2497679C2 (ru) 2008-10-02 2013-11-10 Милан Инк. Способ получения многослойного клеящегося ламинированного материала
EP2201951A1 (de) * 2008-11-14 2010-06-30 Ahmet Melih Aydinoglu Octenidin-Zusammensetzung
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
LT3284459T (lt) 2011-04-29 2021-04-12 Moberg Pharma Ab Farmacinės kompozicijos, apimančios vietinį anestetiką, tokį kaip bupivakainas, skirtos vietiniam įvedimui į burną arba gerklę
DE102012000976A1 (de) * 2012-01-20 2013-07-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Behandlung
DE102012007212A1 (de) 2012-04-11 2013-10-17 Merz Pharma Gmbh & Co. Kgaa Zubereitung zur topischen Anwendung auf Schleimhäuten mit Polyhexanid als Wirkstoff
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
DE102013000700A1 (de) * 2012-10-04 2014-04-10 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung, insbesondere pharmazeutische Zusammensetzung, insbesondere zur Verabreichung bei Heiserkeit und Halsschmerzen
US9789066B2 (en) 2014-01-10 2017-10-17 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US12295923B2 (en) 2018-12-27 2025-05-13 Solventum Intellectual Properties Company Antimicrobial compositions with 1,2-alkanediols
KR20250160891A (ko) 2023-01-16 2025-11-14 유니베르시타트 자우메 프리메 임플란트 주위염의 치료 또는 예방을 위한 코팅 조성물 및 그의 제조 방법
EP4615450A1 (de) * 2023-03-02 2025-09-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH Zusammensetzung enthaltend octenidin für die antivirale behandlung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210386A (en) * 1983-12-09 1987-11-27 Sterling Drug Inc Saccharine salts and dentrifice compositions
AU7204787A (en) * 1986-03-17 1987-10-09 Oral Research Laboratories, Inc. Treatment of dental surfaces with plaque retardants
GB9204410D0 (en) * 1992-02-29 1992-04-15 Smithkline Beecham Plc Method of treatment
US6350438B1 (en) * 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
DE10026716A1 (de) * 2000-05-30 2001-12-13 Ferton Holding Sa Prophylaktische Mundspüllösung
JP2004517038A (ja) * 2000-06-30 2004-06-10 ザ、プロクター、エンド、ギャンブル、カンパニー 全身の健康増進
DE10205883A1 (de) * 2002-02-13 2003-08-21 Schuelke & Mayr Gmbh Wässriges Antiseptikum auf Basis von Bispyridiniumalkanen

Also Published As

Publication number Publication date
HRP20080438T3 (en) 2008-10-31
UA83320C2 (ru) 2008-06-25
ATE398441T1 (de) 2008-07-15
EA011991B1 (ru) 2009-06-30
DE102004052308A1 (de) 2006-04-13
CN101052373B (zh) 2010-06-16
DE502005004475D1 (de) 2008-07-31
EP1799186B1 (de) 2008-06-18
RS50593B (sr) 2010-05-07
HK1108835A1 (en) 2008-05-23
WO2006039961A1 (de) 2006-04-20
PL1799186T3 (pl) 2008-11-28
SI1799186T1 (sl) 2008-10-31
EP1799186A1 (de) 2007-06-27
GEP20094809B (en) 2009-10-26
ES2309790T3 (es) 2008-12-16
EA200700777A1 (ru) 2007-10-26
DE102004052308B4 (de) 2013-04-04
CN101052373A (zh) 2007-10-10

Similar Documents

Publication Publication Date Title
ATE398441T1 (de) Octenidinhaltige lutschtabletten gegen entzündliche erkrankungen des mund- und rachenraums
DK1471890T3 (da) Farmaceutisk doseringsform til mukös afgivelse
NO20072767L (no) Gabapentin prodrug vedvarende frigivelse orale doseringsformer
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
JP2007523091A5 (no)
IS8726A (is) Meðferðarfræðilegar samsetningar þrýstingslækkandi efna og efna sem hamla gegn æðamyndun
SE0102276D0 (sv) Device and method for the administration of a medicament
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
NZ511999A (en) Pharmaceutical formulation comprising a H+,K+-ATPase inhibitor and a gastric antisecretory prostaglandin analogue
WO2008022189A3 (en) Administration of high potency platinum compound formulations by inhalation
EP2043637A4 (en) METHOD AND MEDICAMENTS FOR THE ADMINISTRATION OF IBUPROFEN
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
MX2010006284A (es) Formulaciones farmaceuticas de fenilefrina y composiciones para la absorcion transmucosal.
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
WO2005053719A3 (en) Compositions for the treatment of diseases of the oral cavity and upper respiratory tract
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
MY144781A (en) Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
WO2006072940A3 (en) Controlled long acting release pharmaceutical preparation for use in the oral cavity
JP2002540148A5 (no)
SE9902597D0 (sv) New use
PL1778209T3 (pl) Sposoby i kompozycje do doustnego dostarczania FTS
ATE413187T1 (de) Pharmazeutische zusammensetzungen mit interferon- tau
PT1639998E (pt) Comprimido de chupar à base de fármaco mucilaginoso contra doenças inflamatórias da cavidade bucal e faríngea
WO2006079910A3 (en) 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity
EA200601514A1 (ru) Производные пиперазинмочевины для лечения эндометриоза

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application